| 34740631 | Molecular and Clinical Characterization of Human Adenovirus E4-Associated Conjunctivitis. | Am J Ophthalmol | 2022 |
| 36531578 | Machine Learning Prediction of Adenovirus D8 Conjunctivitis Complications from Viral Whole-Genome Sequence. | Ophthalmol Sci | 2022 |
| 29602567 | Determinants of Outcomes of Adenoviral Keratoconjunctivitis. | Ophthalmology | 2018 |
| 28458509 | Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin. | Clin Ophthalmol | 2017 |
| 27279412 | Evaluating the role of embolization and carotid artery sacrifice and reconstruction in the management of carotid body tumors. | Laryngoscope | 2016 |
| 26038392 | Carotid Artery Sacrifice and Reconstruction in the Setting of Advanced Head and Neck Cancer. | Otolaryngol Head Neck Surg | 2015 |
| 25136406 | Management of carotid artery trauma. | Craniomaxillofac Trauma Reconstr | 2014 |
| 23341010 | Broad-spectrum virucidal activity of (NVC-422) N,N-dichloro-2,2-dimethyltaurine against viral ocular pathogens in vitro. | Invest Ophthalmol Vis Sci | 2013 |
| 22074357 | Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat. | J Pediatr Ophthalmol Strabismus | 2012 |
| 22562783 | Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis. | Adv Ther | 2012 |
| 20875711 | Traumatic internal carotid artery injury treated with overlapping bare metal stents under intravascular ultrasound guidance. | J Vasc Surg | 2011 |
| 21604820 | The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis. | Clin Drug Investig | 2011 |
| 21681652 | Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis. | Adv Ther | 2011 |
| 21060106 | Metallo-beta-lactamase production by Pseudomonas otitidis: a species-related trait. | Antimicrob Agents Chemother | 2011 |
| 20174904 | Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens. | Adv Ther | 2010 |
| 20463315 | A highly virulent Staphylococcus aureus: rabbit anterior chamber infection, characterization, and genetic analysis. | Invest Ophthalmol Vis Sci | 2010 |
| 19192973 | Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis. | Curr Med Res Opin | 2009 |
| 20028267 | Re: Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis. | J Ocul Pharmacol Ther | 2009 |
| 19116600 | Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature. | Pediatr Infect Dis J | 2009 |
| 19293445 | DNA sequencing by Microseq kit targeting 16S rRNA gene for species level identification of mycobacteria. | Indian J Med Res | 2009 |
| 18369536 | The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment. | Adv Ther | 2008 |
| 19043945 | A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis. | J Pediatr Ophthalmol Strabismus | 2008 |
| 18309465 | Ocular distribution, bactericidal activity and settling characteristics of TobraDex ST ophthalmic suspension compared with TobraDex ophthalmic suspension. | Adv Ther | 2008 |
| 17606592 | Choosing the best practice: evidence to support fluoroquinolone drops for acute otitis media through tympanostomy tubes. | Pediatrics | 2007 |
| 18029337 | Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: clinical implications and a review of kinetics of kill studies. | Adv Ther | 2007 |
| 16585681 | Pseudomonas otitidis sp. nov., isolated from patients with otic infections. | Int J Syst Evol Microbiol | 2006 |
| 16966141 | Virulence factor profiles and antimicrobial susceptibilities of ocular bacillus isolates. | Curr Eye Res | 2006 |
| 16880248 | Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. | Pediatrics | 2006 |
| 16491721 | Controlling contagious bacterial conjunctivitis. | J Pediatr Ophthalmol Strabismus | 2006 |
| 16257308 | In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. | Surv Ophthalmol | 2005 |
| 28221457 | A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis. | Eur J Ophthalmol | 2005 |
| 16167284 | A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis. | Eur J Ophthalmol | 2005 |
| 16213934 | Microbiology of acute otitis media with tympanostomy tubes. | Otolaryngol Head Neck Surg | 2005 |
| 14702493 | Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. | Pediatrics | 2004 |
| 15324520 | Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. | Curr Med Res Opin | 2004 |
| 14660913 | Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. | Laryngoscope | 2003 |
| 12974053 | Update on methods of assessing microbiologic success or failure in patients with otic disease. | Ear Nose Throat J | 2003 |
| 12410042 | Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis. | Cornea | 2002 |
| 12169893 | Microbiology of acute otitis externa. | Laryngoscope | 2002 |
| 11685070 | Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis. | Cornea | 2001 |
| 11801996 | Microbiology of normal external auditory canal. | Laryngoscope | 2001 |
| 11821987 | The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis. | Curr Eye Res | 2001 |
| 10817723 | Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998). | Antimicrob Agents Chemother | 2000 |
| 10550795 | Serratia marcescens keratitis: strain-specific corneal pathogenesis in rabbits. | Curr Eye Res | 1999 |
| 6630064 | U-56,407, a new antibiotic related to asukamycin: isolation and characterization. | J Antibiot (Tokyo) | 1983 |
| 404965 | Microbial formation of 4-thiouracil. | Antimicrob Agents Chemother | 1977 |